Friday, March 17, 2017

Should The U.S. Government Buy A Drug Company To Save Money?

Should The U.S. Government Buy A Drug Company To Save Money?
March 17, 20173:49 PM ET

President Donald Trump says the pharmaceutical industry is "getting away with murder," and he's vowed to do something about it.

So what could he do in the case of hepatitis C medications?

One solution that's been proposed is to buy the company. Specifically buy Gilead Sciences Inc.
Dr. Peter Bach, the director of health policy and outcomes at Memorial Sloan Kettering Cancer Center in New York, says the U.S. government could save money and treat everyone in the nation who has hepatitis C if it bought Gilead Sciences, rather than just buying Gilead's products.

Read the article, here....

No comments:

Post a Comment